FDA Approves First Nonsteroidal Drug for DMD
U.S. Food and Drug Administration
The FDA granted the approval of Duvyzat™ to Italfarmaco S.p.A
Phase 1/2 trial showed the safety and therapeutic potential of administering a novel transgene
Researchers are finding clues that may help treat rare and deadly diseases using mini-organs and advanced technology